Literature DB >> 7624324

MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase.

S Xu1, D Robbins, J Frost, A Dang, C Lange-Carter, M H Cobb.   

Abstract

A constitutively active fragment of rat MEK kinase 1 (MEKK1) consisting of only its catalytic domain (MEKK-C) expressed in bacteria quantitatively activates recombinant mitogen-activated protein (MAP) kinase/extracellular signal-regulated protein kinase (ERK) kinases 1 and 2 (MEK1 and MEK2) in vitro. Activation of MEK1 by MEKK-C is accompanied by phosphorylation of S218 and S222, which are also phosphorylated by the protein kinases c-Mos and Raf-1. MEKK1 has been implicated in regulation of a parallel but distinct cascade that leads to phosphorylation of N-terminal sites on c-Jun; thus, its role in the MAP kinase pathway has been questioned. However, in addition to its capacity to phosphorylate MEK1 in vitro, MEKK-C interacts with MEK1 in the two-hybrid system, and expression of mouse MEKK1 or MEKK-C in mammalian cells causes constitutive activation of both MEK1 and MEK2. Neither cotransfected nor endogenous ERK2 is highly activated by MEKK1 compared to its stimulation by epidermal growth factor in spite of significant activation of endogenous MEK. Thus, other as yet undefined mechanisms may be involved in determining information flow through the MAP kinase and related pathways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624324      PMCID: PMC41418          DOI: 10.1073/pnas.92.15.6808

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF.

Authors:  T G Boulton; S H Nye; D J Robbins; N Y Ip; E Radziejewska; S D Morgenbesser; R A DePinho; N Panayotatos; M H Cobb; G D Yancopoulos
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

2.  Improved method for high efficiency transformation of intact yeast cells.

Authors:  D Gietz; A St Jean; R A Woods; R H Schiestl
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

3.  Transformation of mammalian cells by constitutively active MAP kinase kinase.

Authors:  S J Mansour; W T Matten; A S Hermann; J M Candia; S Rong; K Fukasawa; G F Vande Woude; N G Ahn
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

Review 4.  MAP kinases ERK1 and ERK2: pleiotropic enzymes in a ubiquitous signaling network.

Authors:  D J Robbins; E Zhen; M Cheng; S Xu; D Ebert; M H Cobb
Journal:  Adv Cancer Res       Date:  1994       Impact factor: 6.242

5.  Ste5 tethers multiple protein kinases in the MAP kinase cascade required for mating in S. cerevisiae.

Authors:  K Y Choi; B Satterberg; D M Lyons; E A Elion
Journal:  Cell       Date:  1994-08-12       Impact factor: 41.582

6.  RAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2.

Authors:  T Jelinek; A D Catling; C W Reuter; S A Moodie; A Wolfman; M J Weber
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

7.  Inhibition of platelet-derived growth factor- and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing delta Raf-1:ER, an estradiol-regulated form of Raf-1.

Authors:  M L Samuels; M McMahon
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Purification and properties of extracellular signal-regulated kinase 1, an insulin-stimulated microtubule-associated protein 2 kinase.

Authors:  T G Boulton; J S Gregory; M H Cobb
Journal:  Biochemistry       Date:  1991-01-08       Impact factor: 3.162

9.  Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK.

Authors:  A Minden; A Lin; M McMahon; C Lange-Carter; B Dérijard; R J Davis; G L Johnson; M Karin
Journal:  Science       Date:  1994-12-09       Impact factor: 47.728

10.  MEK-1 phosphorylation by MEK kinase, Raf, and mitogen-activated protein kinase: analysis of phosphopeptides and regulation of activity.

Authors:  A M Gardner; R R Vaillancourt; C A Lange-Carter; G L Johnson
Journal:  Mol Biol Cell       Date:  1994-02       Impact factor: 4.138

View more
  49 in total

Review 1.  Mitogen-activated protein kinases: specific messages from ubiquitous messengers.

Authors:  H J Schaeffer; M J Weber
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export.

Authors:  S H Hong; M L Privalsky
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK.

Authors:  J L Swantek; M H Cobb; T D Geppert
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.

Authors:  James A McCubrey; Linda S Steelman; Richard A Franklin; Steven L Abrams; William H Chappell; Ellis W T Wong; Brian D Lehmann; David M Terrian; Jorg Basecke; Franca Stivala; Massimo Libra; Camilla Evangelisti; Alberto M Martelli
Journal:  Adv Enzyme Regul       Date:  2007-03-26

Review 5.  The interferon signaling network and transcription factor C/EBP-beta.

Authors:  Hui Li; Padmaja Gade; Weihua Xiao; Dhan V Kalvakolanu
Journal:  Cell Mol Immunol       Date:  2007-12       Impact factor: 11.530

6.  Chromatin-bound mitogen-activated protein kinases transmit dynamic signals in transcription complexes in beta-cells.

Authors:  Michael C Lawrence; Kathleen McGlynn; Chunli Shao; Lingling Duan; Bashoo Naziruddin; Marlon F Levy; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-28       Impact factor: 11.205

7.  Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.

Authors:  James A McCubrey; Melissa L Sokolosky; Brian D Lehmann; Jackson R Taylor; Patrick M Navolanic; William H Chappell; Stephen L Abrams; Kristin M Stadelman; Ellis W T Wong; Negin Misaghian; Stefan Horn; Jörg Bäsecke; Massimo Libra; Franca Stivala; Giovanni Ligresti; Agostino Tafuri; Michele Milella; Marek Zarzycki; Andrzej Dzugaj; Francesca Chiarini; Camilla Evangelisti; Alberto M Martelli; David M Terrian; Richard A Franklin; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2008-02-21

Review 8.  Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

Authors:  James A McCubrey; Stephen L Abrams; Kristin Stadelman; William H Chappell; Michelle Lahair; Richard A Ferland; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2009-11-04

9.  Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins.

Authors:  J A Frost; H Steen; P Shapiro; T Lewis; N Ahn; P E Shaw; M H Cobb
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

10.  Cloning of rat MEK kinase 1 cDNA reveals an endogenous membrane-associated 195-kDa protein with a large regulatory domain.

Authors:  S Xu; D J Robbins; L B Christerson; J M English; C A Vanderbilt; M H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.